NYSE:ORB

Orbital Sciences Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.

Add

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive ORB News and Ratings via Email

Sign-up to receive the latest news and ratings for Orbital Sciences and its competitors with MarketBeat's FREE daily newsletter.

About Orbital Sciences

Orbital Sciences Corporation develops and manufactures rockets and space systems for commercial, military and civil government customers, including the United States Department of Defense (DoD), the National Aeronautics and Space Administration (NASA), other Unites States Government agencies and commercial satellite operators. The Company operates in three segments, including launch vehicles, satellites and space systems, and advanced space programs. Launch Vehicles segment includes rockets that are used as space launch vehicles. Satellites and Space Systems segment satellites that are used to enable communications and broadcasting, conduct space-related scientific research, other deep-space exploration missions and demonstrate new space technologies. Advanced Space Programs segment includes human-rated space systems for Earth-orbit and deep-space exploration, and satellites used for national security space programs and to demonstrate new space technologies.

Blue Origin announces its commercial space station, Orbital Reef, will be operational by 2030
October 25, 2021 | msn.com

Kempf named chief marketing officer at Geospace
October 14, 2021 | msn.com

Meet the crew of NS18! Blue Origin shares a new photo of the four astronauts preparing to launch into space tomorrow, including Star Trek legend William Shatner, 90, who jokes ...
October 12, 2021 | msn.com

William Shatner, Star Trek's Captain Kirk, will blast off to space on Blue Origin capsule on October 12
October 4, 2021 | msn.com

Blue Origin unveils date, first two crew members for October suborbital spaceflight
September 27, 2021 | msn.com

After milestone flight, Blue Origin SVP Stephen Bennett will join Kepler Communications as COO
September 14, 2021 | msn.com

Police watchdog organization investigating arrest by Winnipeg cops that led to orbital fracture
September 13, 2021 | msn.com

Boeing’s Starliner CST-100 test flight postponed again: Everything to know about NASA’s Commercial Crew programme
August 4, 2021 | msn.com

DEDUCED RECKONING: Space business is hard, risky, and unprofitable
July 14, 2021 | msn.com

Changes In Planet’s Orbit Allowed Life To Survive ‘Snowball Earth’
July 9, 2021 | forbes.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: N/A
Sub-Industry: Aerospace & Defense
Sector: N/A
Current Symbol: NYSE:ORB
Previous Symbol
CUSIP: 68556410
CIK: 820736
Web: www.orbital.com
Phone: +1-703-4065524
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.88 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Orbital Sciences.

4.4 Community Rank

Outperform Votes
Orbital Sciences has received 138 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Orbital Sciences has received 68 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Orbital Sciences has received 66.99% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Orbital Sciences and other stocks. Vote “Outperform” if you believe ORB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ORB will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Orbital Sciences does not currently pay a dividend.
Dividend Growth
Orbital Sciences does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Orbital Sciences insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Orbital Sciences (NYSE:ORB) Frequently Asked Questions

What stocks does MarketBeat like better than Orbital Sciences?: Wall Street analysts have given Orbital Sciences a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Orbital Sciences wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
Who are some of Orbital Sciences' key competitors?: Some companies that are related to Orbital Sciences include Honeywell International (HON), The Boeing (BA), Lockheed Martin (LMT), Northrop Grumman (NOC), General Dynamics (GD), TransDigm Group (TDG), Teledyne Technologies (TDY), HEICO (HEI), Textron (TXT), Huntington Ingalls Industries (HII), Curtiss-Wright (CW), Hexcel (HXL), Spirit AeroSystems (SPR), Aerojet Rocketdyne (AJRD) and Kratos Defense & Security Solutions (KTOS).
View all of ORB's competitors.
What other stocks do shareholders of Orbital Sciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Orbital Sciences investors own include ANI Pharmaceuticals (ANIP), Delta Air Lines (DAL), Ford Motor (F), General Motors (GM), Novavax (NVAX), United Airlines (UAL), Altaba (AABA), American Airlines Group (AAL), ACADIA Pharmaceuticals (ACAD) and Acorda Therapeutics (ACOR).
What is Orbital Sciences' stock symbol?: Orbital Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "ORB."
What is Orbital Sciences' official website?: The official website for Orbital Sciences is www.orbital.com.
Where are Orbital Sciences' headquarters?: Orbital Sciences is headquartered at 45101 Warp Dr, DULLES, VA 20166-6874, United States.
How can I contact Orbital Sciences?: Orbital Sciences' mailing address is 45101 Warp Dr, DULLES, VA 20166-6874, United States. The company can be reached via phone at +1-703-4065524.

This page was last updated on 10/27/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.